Name Surname: GÖKHAN KABAÇAM

Güven Hospital

Department: Internal Medicine

Academic Title: Professor

Title: Professor

CV: Download

CV

Name: Gökhan Kabaçam
DOB: 10/10/1977
Place of Birth: Ankara
Academic Title: Professor in Medicine
Current Affiliations: 
Guven Hospital Dept’s of Gastroenterology and Liver Transplantation, Ankara
Yuksek Ihtisas University School of Medicine Dept of Internal Medicine, Ankara

E-mail: gokhankabacam@yahoo.com

Society membership:

    Turkish Society of Gastroenterology
    Turkish Association for the Study of the Liver
    ILTS (International Liver Transplantation Society) – Membership and Communications Committee (Vice Chair)
    AASLD (American Association for the Study of Liver) 
    EASL (European Scociety of the Study of Liver) 

Editorial Work:

•    Turkish Journal of Gastroenterology, Associate Editor, Current
•    Hepatology Forum, Associate Editor, Current
•    Health Sciences Reviews, Associate Editor, Current 

Recognitions:

•    1999 – Hacettepe Tip Fakültesi İç Hastalıkları Şeref Zileli Most Successful Student of the year
•    2010 – EASL Young investigator
G. Kabaçam, F.O. Önder, G. Seven, M. Yakut, H. Bozkaya, M.A. Bozdayı, R. İdilman, C. Yurdaydın, 45th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 52 Supp" bildiri kitapçığındaki "Outcome and virological changes during the follow up of a large single center cohort of chronic delta hepatitis patients", S133 pp., Viyana, Avusturya, Nisan 2010

•    2011 – EASL Young investigator
G. Kabacam, M. Yakut, G. Seven, H. Bozkaya, R. Idilman, C. Yurdaydin. 46th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 54 Supp No:1" bildiri kitapçığındaki “Interferon Treatment Of Delta Hepatitis: The Longer The Duration The Better The Success?”, S290 pp., Berlin, Almanya, Nisan 2011

•    2010 – EASL Young investigator
G Kabacam, H Wedemeyer, B Heidrich, K Yalçın, FO Önder, Hans P. Dienes, Michael P. Manns, C Yurdaydın. “Immunehistochemistry for HBSAG, HBCAG, and HDAG in Chronic Delta Hepatitis and effect of treatment.” EASL Monothematic Conference on Delta Hepatitis 2010. P 48, Istanbul, Turkiye. Eylul 2010.

•    2010 – EASL Young investigator (FO Önder, M Toy, JH Richardus, R İdilman, G.Kabaçam, H Değertekin, K Yalçın, S Schalm, C Yurdaydın. “An aggregated analysis of delta hepatitis in Turkey and the quantification of burden of disease.” EASL Monothematic Conference on Delta Hepatitis 2010. P 74. Istanbul, Turkiye. Eylul 2010.

•    2010 – Best verbal presentation 
M Toy, FO Onder, R Idilman, D Oguz, M Akdogan, G Kabacam, JH Richardus, M Bozdayi, Z Kuloglu, A Kansu, S Schalm, C Yurdaydin. “Turkiye’de  uzun donemde HBV’ye bagli beklenen morbidite ve mortalitenin önlenmesinde takibin ve tedavi alternatiflerinin maliyet – etkinlik analizi.” 27. Ulusal Gastroenteroloji Haftasi, Turk J Gastroenterol, volüme 21, suppl 1: 4 - 5 pp, Antalya, Turkiye. Kasim 2010.

•    2009 – 2nd Best verbal presentation
G Kabaçam, H Wedemeyer, B Savaş, H Bozkaya, B Heidrich, K Yalçın, FO Önder, E Erden, US Akarca, H Şentürk, S Gürel, Y Çakaloğlu, H Dienes, M Manns, C Yurdaydın. “Kronik Delta Hepatitinde HBsAg, HBcAg ve HDAg İmmünohistokimyası ve Tedavinin Etkisi” 7. Ulusal Hepatoloji Kongresi, Bildiri Kitabi; 40 pp, Izmir, Turkiye. Haziran 2009.

Publications: 

A. International Papers:
A1:    Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed
M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calışkan AR,
Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder
A, Parés A, Llovet L, Akyıldız M, Arikan C, Manns MP, Taubert R, Weber AL,
Schiano TD, Haydel B, Czubkowski P, Socha P, Ołdak N, Akamatsu N, Tanaka A, Levy
C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M,
Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van
Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani
A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM,
Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH;
International Autoimmune Hepatitis Group (IAIHG). Risk factors and outcomes
associated with recurrent autoimmune hepatitis following liver transplantation.
J Hepatol. 2022 Jul;77(1):84-97. doi: 10.1016/j.jhep.2022.01.022. Epub 2022 Feb
8. PMID: 35143897.
A2:    Kabaçam G, Wahlin S, Efe C. Autoimmune hepatitis triggered by COVID-19: A
report of two cases. Liver Int. 2021 Oct;41(10):2527-2528. doi:10.1111/liv.15044. Epub 2021 Sep 3. PMID: 34478591.

A3:    Akarsu M, Onem S, Turan I, Adali G, Akdogan M, Akyildiz M, Aladag M, Balaban
Y, Danis N, Dayangac M, Gencdal G, Gokcan H, Sertesen E, Gurakar M, Harputluoglu
M, Kabacam G, Karademir S, Kiyici M, Idilman R, Karasu Z. Recommendations for
Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B
Recurrence After Liver Transplantation. Turk J Gastroenterol. 2021
Sep;32(9):712-719. doi: 10.5152/tjg.2021.21608. PMID: 34609299.
A4:    Müller PC, Kabacam G, Vibert E, Germani G, Petrowsky H. Current status of
liver transplantation in Europe. Int J Surg. 2020 Oct;82S:22-29. doi:
10.1016/j.ijsu.2020.05.062. Epub 2020 May 23. PMID: 32454252. (SCI-E)
A5:    Ogura Y, Kabacam G, Singhal A, Moon DB. The role of living donor liver
transplantation for acute liver failure. Int J Surg. 2020 Oct;82S:145-148. doi:
10.1016/j.ijsu.2020.04.058. Epub 2020 Apr 28. PMID: 32353557. (SCI-E)
A6:    Chadha R, De Martin E, Kabacam G, Kirchner V, Kalisvaart M, Goldaracena N,
Tanaka T, Spiro M, Sapisochin G, Vinaixa C, Hessheimer A, Campos Varela I,
Rammohan A, Yoon YI, Victor D, Scalera I, Chan A, Bhangui P. Proceedings of the
25th Annual Congress of the International Liver Transplantation Society.
Transplantation. 2020 Aug;104(8):1560-1565. doi: 10.1097/TP.0000000000003160.
PMID: 32732832. (SCI-E)
A7:    Kabaçam G, Dayangaç M, Üçbilek E, Erçin CN, Günsar F, Akyıldız M, Akarsu M,
Demir M, Kaymakoğlu S, Karasu Z, İdilman R. The COVID-19 pandemic: Clinical
practice advice for gastroenterologists, hepatologists, and liver transplant
specialists. Turk J Gastroenterol. 2020 May;31(5):348-355. doi:
10.5152/tjg.2020.20413. PMID: 32519953; PMCID: PMC7289168. (SCI-E)
A8:               De Martin E, Hessheimer A, Chadha R, Kabacam G, Rajanayagam J, Kirchner V,
Kalisvaart M, Scalera I, Bhat M, Contreras A, Bhangui P. Report of the 24th
Annual Congress of the International Liver Transplantation Society.
Transplantation. 2019 Mar;103(3):465-469. doi: 10.1097/TP.0000000000002549.
PMID: 30461723. (SCI-E)
A9:    Yurdaydin C, Keskin O, Kalkan Ç, Karakaya F, Çaliskan A, Kabaçam G, Önder FO, 
Karatayli S, Karatayli E, Deda X, Bozkaya H, Bozdayi AM, Idilman R. Interferon
Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the
Natural Course of the Disease. J Infect Dis. 2018 Mar 28;217(8):1184-1192. doi:
10.1093/infdis/jix656. PubMed PMID: 29425306. (SCI-E)
A10:    Niranjan-Azadi AM, Kabaçam G, Durand CM, Anjum S, Saberi B, Dagher NN, Philosophe B, Gurakar A. Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA). Ann Transplant. 2017 Sep 22;22:570-574. PubMed PMID: 28935852. (SCI-E)
A11:              Karakaya F, Özer S, Kalkan Ç, Tüzün EA, Çalışkan A, Keskin O, Kabaçam G,
Karatayli S, Karatayli E, Bozdayi AM, Idilman R, Yurdaydin C. Discontinuation of 
lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with
long-term follow-up. Antivir Ther. 2017 Feb 27. doi: 10.3851/IMP3144. [Epub ahead
of print] PubMed PMID: 28240596. (SCI-E)
A12:             Abdelqader A, Kabacam G, Woreta TA, Hamilton JP, Luu H, Al Khalloufi K, Saberi
B, Philosophe B, Cameron AM, Gurakar A. Pre- Versus Posttransplant Treatment of
Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients:
More Issues to be Solved. Exp Clin Transplant. 2017 Feb;15(Suppl 1):1-5. PubMed
PMID: 28260422. (SCI-E)
A13:    Bektas M, Seven G, Idilman R, Yakut M, Doğanay B, Kabacam G, Ustun Y, Korkut E, Kalkan Ç, Sahin G, Cetinkaya H, Bozkaya H, Yurdaydin C, Bahar K, Cinar K, Soykan I. Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis. Eur J Intern Med. 2014 Mar;25(3):230-4. doi: 10.1016/j.ejim.2014.01.008. Epub 2014 Feb 16. PubMed PMID: 24534163. (SCI-E)
A14:    Heidrich B, Yurdaydın C, Kabaçam G, Ratsch BA, Zachou K, Bremer B, Dalekos GN, Erhardt A, Tabak F, Yalcin K, Gürel S, Zeuzem S, Cornberg M, Bock CT, Manns MP, Wedemeyer H; for the HIDIT-1 Study group. Late HDV RNA relapse after peginterferon alfa-based therapy of chronic hepatitis delta. Hepatology. 2014 Feb 28. doi: 10.1002/hep.27102. [Epub ahead of print] PubMed PMID: 24585488. (SCI)
A15:    Keskin O, Ormeci AC, Baran B, Kabaçam G, Tuzun A, Karatayli E, Akyüz F, Karatayli S, Bozdayi AM, Onel D, Badur S, Idilman R, Kaymakoglu S, Yurdaydin C. Efficacy of tenofovir in adefovir-experienced patients compared to treatment-naive patients with chronic hepatitis B. Antivir Ther. 2014 Feb 12. doi: 10.3851/IMP2732. [Epub ahead of print] PubMed PMID: 24517926. (SCI-E)
A16:    Özkan H, Arslan M, Kabacam G, Tas A, Özgür G, Kaygusuz G, Ekinci C, Serdaroğlu A, Köklü S. Chronic hepatitis in a patient with rigid spine myopathy: Cause or just an association? Turk J Gastroenterol 2014; 25: 113-5. (SCI-E)
A17:    Kabaçam G, Wedemeyer H, Savaş B, Keskin O, Dalekos G, Tabak F, Idilman R, Erhardt A, Yalçın K, Bozdayi MA, Bozkaya H, Manns M, Dienes H, Yurdaydın C; the HIDIT-1 Study Group. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta. Liver Int. 2013 Nov 5. doi: 10.1111/liv.12376. [Epub ahead of print] PubMed PMID: 24308704. (SCI-E)
A18:    Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C. Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir. Antivir Ther. 2013;18(1):77-85. doi: 10.3851/IMP2294. Epub 2012 Aug 10. PubMed PMID: 22878399. (SCI-E)
A19:    Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013 Jun;267(3):767-75. doi: 10.1148/radiol.13121360. Epub 2013 Feb 4. PubMed PMID: 23382293. (SCI-E)
A20:    Kabaçam GB, Akbıyık F, Livanelioğlu Z, Tiryaki HT, Karakuş E, Kabaçam G. Decision for surgery in the management of a rare condition, childhood gallbladder polyps, and the role of ultrasonography. Turk J Gastroenterol. 2013;24(6):556-60. PubMed PMID: 24623297. (SCI-E)
A21:    Heidrich B, Serrano BC, Idilman R, Kabaçam G, Bremer B, Raupach R, Önder FO,  Deterding K, Zacher BJ, Taranta A, Bozkaya H, Zachou K, Tillmann HL, Bozdayi AM, Manns MP, Yurdaydın C, Wedemeyer H. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver Int. 2012 Oct;32(9):1415-25. doi: 10.1111/j.1478-3231.2012.02831.x. Epub 2012 Jun 20. PubMed PMID: 22716112. (SCI-E)
A22:    Toy M, Onder FO, Idilman R, Kabacam G, Richardus JH, Bozdayi M, Akdogan M, Kuloglu Z, Kansu A, Schalm S, Yurdaydin C. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. Eur J Health Econ. 2012 Oct;13(5):663-76. doi: 10.1007/s10198-012-0413-8. Epub 2012 Jul 20. PubMed PMID: 22815098; PubMed Central PMCID: PMC3427846. (SSCI)
A23:    Kabaçam G, Onder FO, Yakut M, Seven G, Karatayli SC, Karatayli E, Savas B, Idilman R, Bozdayi AM, Yurdaydin C. Entecavir treatment of chronic hepatitis D. Clin Infect Dis. 2012 Sep;55(5):645-50. doi: 10.1093/cid/cis459. Epub 2012 May 9. PubMed PMID: 22573857. (SCI-E)
A24:    Kabaçam G, Dalekos GN, Çakaloğlu Y, Zachou K, Bock T, Erhardt A, Zeuzem S, Tabak F, Yalçin K, Bozdayi AM, Dienes HP, Bozkaya H, Manns M, Wedemeyer H, Yurdaydin C. Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol. 2012;23(5):560-8. PubMed PMID: 23161302. (SCI-E)
A25:    Kabaçam G, Törüner M. Can azathioprine 6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: what is the most appropriate time for this? Turk J Gastroenterol. 2012;23 Suppl 2:17-20. Review. PubMed PMID: 23576085. (SCI-E)
A26:    Kabaçam G, Törüner M. How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment? Turk J Gastroenterol. 2012;23 Suppl 2:13-6. Review. PubMed PMID: 23576084. (SCI-E)
A27:    Kabaçam G, Yakut M, Soykan I. Acute esophageal necrosis: a rare cause of gastrointestinal bleeding. Dig Endosc. 2012 Jul;24(4):283. doi: 10.1111/j.1443-1661.2011.01198.x. PubMed PMID: 22725119. (SCI-E)
A28:    Yakut M, Ustün Y, Kabaçam G, Bektaş M, Soykan I. Gallbladder volume and ejection fraction in patients with Behçet's disease. Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):e20-1. doi: 10.1016/j.clinre.2011.08.009. Epub 2011 Oct 1. PubMed PMID: 21963045. (SCI-E)
A29:    AK Dokmeci, M Yakut, N Ormeci, H Ozkan, G Kabacam. Long – term results of pancreaticoduodenectomy and endoscopic resection in the treatment of early stage carcinoma of the ampulla of Vater: case series and review of the literature. Turk J Med Sci 2012; 42(5): 946 – 50. (SCI-E)
A30:    Yakut M, Ustün Y, Kutlay S, Ongun A, Kabaçam G, Boynueğri R, Soykan I. Multiparametric assessment of vascular function and atherosclerosis in patients with autoimmune gastritis: a comparative study. Dig Dis Sci. 2011 Dec;56(12):3583-9. doi: 10.1007/s10620-011-1778-8. Epub 2011 Jun 17. PubMed PMID: 21681509. (SCI-E)
A31:    Yakut M, Kabacam G, Bektaş M, Cetinkaya H, Toruner M, Soykan I. The effect of endogenous hypergastrinemia on lower esophageal sphincter pressure and esophageal motility. Hepatogastroenterology. 2011 Nov-Dec;58(112):1989-92. doi: 10.5754/hge11028. PubMed PMID: 22024072.
A32:    Yakut M, Kabaçam G, Üstün Y, Cetinkaya H, Soykan I. Hepatitis B and C virus prevalence and related factors in patients with inflammatory bowel diseases. Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):857. doi: 10.1016/j.clinre.2011.08.005. Epub 2011 Oct 2. PubMed PMID: 21963993 (SCI-E)
A33:    Seven G, Karatayli SC, Köse SK, Yakut M, Kabaçam G, Törüner M, Heper AO, Voelker M, Erden E, Bozdayi AM, Uzunalımoğlu O, Bozkaya H, Yurdaydin C, Schuppan  D. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D. Turk J Gastroenterol. 2011 Jun;22(3):305-14. PubMed PMID: 21805422. (SCI-E)
A34:    Yakut M, Kabaçam G, Öztürk A, Soykan I. Clinical characteristics and evaluation of patients with large hiatal hernia and Cameron lesions. South Med J. 2011 Mar;104(3):179-84. doi: 10.1097/SMJ.0b013e31820c018c. PubMed PMID: 21297527. (SCI-E)
A35:    Yakut M, Ustün Y, Kabaçam G, Soykan I. Thyroid disorders in patients with Inflammatory Bowel Diseases. Int J Clin Med 2011; 2: 89 – 92. (SCI-E)
A36:    Yakut M, Ustün Y, Kabaçam G, Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med. 2010 Aug;21(4):320-3. doi: 10.1016/j.ejim.2010.05.007. Epub 2010 Jun 8. PubMed PMID: 20603044. (SCI-E)
A37:    Kabaçam G, Törüner M. What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease? Turk J Gastroenterol. 2010 Mar;21(1):107-12. Review. PubMed PMID: 20552736. (SCI-E)
A38:    Kabaçam G, Tezel A. When and how frequently DEXA should be performed for the diagnosis and follow-up of osteoporosis in Crohn's disease? Turk J Gastroenterol. 2010 Mar;21(1):100-6. Review. PubMed PMID: 20552735. (SCI-E)
A39:    Kabacam G, Kabacam G, Topcuoglu P, Kuzu I, Arat M. Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature. Turk J Hematol 2010; 27: 190-5. doi:10.5152/tjh.2010.27 (SCI-E)
A40:    Ergun I, Kabacam G, Ekmekci Y, Tulunay O, Keven K, Duman N. Skin nodules and acute renal failure, what is the link? Nephrol Dial Transplant. 2005 Jun;20(6):1269-70. Epub 2005 Feb 22. PubMed PMID: 15728264. (SCI-E)

B. International Congress Presentations:

B1:               I Turan, M Aladag, M Harputluoglu, S Yilmaz, G Gencdal, KY Polat, F Özçay, M Akarsu, T Unek, Z Karasu, M Zeytunlu, H Gokcan Sumer, EB Bostanci, A Caliskan Kartal, D Balci, M Dayangac, D Dincer, H Adanir, H Dursun, MT Gulsen, F Gunduz, HY Balaban, G Kabaçam, M Akyildiz, F Günsar, U Akarca, A Gurakar, R Idilman, Liver Transplantation Special Interest Group Tasl. The Digital Liver Congress 2020 kongresi dahilinde bildiri kitapçığındaki “Outcomes following deceased and live donor liver transplantation for the indication of acute liver failure: a multicenter experience.” J Hepatol, 2020; 73, S227
B2:                G Hatemi, S Akar, H Akpinar, P Atagündüz, G Bengi, G Can, AF Celik, SN Esatoğlu, Ö Gerçik, H Hamzaoglu, M Inanc, G Kabacam, IH Kalkan, L Kılıç, F Onen, A Tezel, M Toruner, S Kiraz. 2019 EULAR kongresi bildiri kitapçığındaki “Evidence Based Recommendations For The Management Of Enteropathic Arthritis: A Rheumatology, Gastroenterology Collaborative Initiative.” Annals of the Rheumatic Diseases 2019; 78 (Suppl 2), 881-881.
B3:                Atli M, Akkan K, Kabacam G, Soylu L, Yagci G, Karademir S. 25th Annual ILTS International Congress kongresi dahilinde bildiri kitapçığındaki “A novel combined surgical and interventional radiological treatment of complete biliary anastomosis obstructions after right lobe living donor liver transplantation” P-520. Toronto, Kanada, Mayıs 2019
B4:                 Kabacam G, Atli M, Cetinkaya Sardan Y, Yagci G, Karademir S. 25th Annual ILTS International Congress kongresi dahilinde bildiri kitapçığındaki “Liver transplantation without antifungal prophylaxis - incidence and outcome: single center experience” P-108. Toronto, Kanada, Mayıs 2019
B5:                  Balci D, Keskin O, Kabacam G, Kirimker O, Atli M, Karayalcin K, Yurdaydin C, Dokmeci A, Karademir S. 25th Annual ILTS International Congress kongresi dahilinde bildiri kitapçığındaki “The presence of preoperative portal vein thrombosis does not affect survival in living donor liver transplantation” P-265. Toronto, Kanada, Mayıs 2019
B6:                  B. Heidrich, C. Yurdaydın, G Kabaçam, K. Zachou, B. Bremer, G.N. Dalekos, A. Erhardt, Y. Cakaloglu, K. Yalcin, S. Gurel, S. Zeuzem, T. Bock, R. Idilman, M.P. Manns, H. Wedemeyer. 48th The International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Supp 58" bildiri kitapçığındaki "Long-Term Follow-Up After Peg-IFNa2a-Based Therapy of Chronic Hepatitis Delta", S20pp (Sozlu sunum), Amsterdam, Hollanda, Nisan 2013 
B7:                   O. Keskin, R. Idilman, B. Evranos, G Kabaçam, S. Turhan, D. Corapcioglu, C. Yurdaydin. 48th The International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Supp 58" bildiri kitapçığındaki " The Effect of Metformin Treatment on Cardiovascular Risk in Patients with Nonalcoholic Fatty Liver Disease", S541pp, Amsterdam, Hollanda, Nisan 2013
B8:                   R Idilman, SC. Karatayli, O Keskin, G Kabaçam, B Savas, A.M Bozdayi, C Yurdaydin, AK Dokmeci. The  annual meeting of the Asia Pacific Accociation for the Study of Liver Diseases kongresi dahilinde “Hepatology Int, volüme 7(Suppl 1)” bildiri kitapçığındaki “Effect of genetic variability of pnpla3 on disease progression of non – alcoholic fatty liver disease.”, S88 pp. Singapur, Mart 2013.
B9:                   O Keskin, R Idilman, B. Evranos, G Kabaçam, S Turhan, D Corapcioglu, AK Dokmeci. The  23th annual meeting of the Asia Pacific Accociation for the Study of Liver Diseases kongresi dahilinde “Hepatology Int, volume 7(Suppl 1)” bildiri kitapçığındaki “The effect of insülin sensitizers on cardiovascular risk in patients with nonalcoholic fatty liver disease”. S89 – S90. Singapur, Mart 2013.
B10:    O. Keskin, A. Ormeci, G Kabaçam, F. Akyuz, H. Aniktar, C. Karaca, R. Idilman, S. Kaymakoglu, C. Yurdaydin. 47th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 56 Supp No:2" bildiri kitapçığındaki “Response To Tenofovir Treatment Of Treatment-Naive Vs Adefovir-Resistant vs Suboptimal Responder Patients With Chronic Hepatitis B”, S206 pp., Barselona, Ispanya, Nisan 2012
B11:    FO. Önder, G Kabaçam, B. Savaş, D. Ozer Etik, E. Öztas, R. Idilman, N. Şaşmaz, E. Kayaçetin, C. Yurdaydin, 47th The International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Supp 56" bildiri kitapçığındaki "Discrepancy of Treatment Guidelines and Liver Biopsy Findings in Hepatitis B Patients", 188-189pp, Barselona, İspanya, Nisan 2012 
B12:    G Kabaçam, H Wedemeyer, B Heidrich, K Yalcin, F O Onder, H P. Dienes, M P. Manns, C Yurdaydin. The 63th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 56; S1" bildiri kitapçığındaki " Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH)", 392 – 3A pp., Boston, ABD, Kasim 2012.
B13:    O Keskin, A Cifcibasi Ormeci, G Kabaçam, F Akyuz, H Aniktar, C Karaca, R Idilman, S Kaymakoglu, C Yurdaydin. The 63th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 56; S1" bildiri kitapçığındaki " Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis B", 394 – 5A pp., Boston, ABD, Kasim 2012.
B14:    M Yakut, O Keskin, G Seven, G Kabaçam, E Karatayli, SC. Karatayli, M Bektas, A M Bozdayi, R Idilman, C Yurdaydin. The 63th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 56; S1" bildiri kitapçığındaki " Characterization of the inactive HBsAG carrier state with 4 years of follow-up", 440A pp., Boston, ABD, Kasim 2012.
B15:    R Idilman, O Keskin, SC. Karatayli, H Aniktar, G Kabaçam, B Savas, K Cinar, A.M Bozdayi, K Bahar, C Yurdaydin. The 63th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 56; S1" bildiri kitapçığındaki " The impact of genetic variability of patatin-like phospholipase domain-containing 3 gene on histological progression of non-alcoholic fatty liver disease: a crosssectional and longitudinal follow-up study. ", 884 – 5A pp., Boston, ABD, Kasim 2012. 
B16:    IS. Idilman, O Keskin, G Kabaçam, B Savas, M Karcaaltincaba, K Cinar, R Idilman. 
The 63th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 56; S1" bildiri kitapçığındaki " The impact of sequential proton density fat fraction calculation by MRI for quantification of hepatic steatosis in nonalcoholic fatty liver disease: a longitudinal follow-up study. ", 904A pp., Boston, ABD, Kasim 2012.
B17:    IS. Idilman, H Aniktar, R Idilman, G Kabaçam, B Savas, A Elhan, A Celik, K Bahar, M Karcaaltincaba. The RSNA meeting of the Radiology Society of North America kongresi dahilinde bildiri kitapçığındaki " Comparison of proton density fat fraction calculation by MRI and liver biopsy for quantification of hepatic steatosis.", 1 – 2 pp., Chicago, ABD, Kasim 2012.
B18:    G Kabaçam, M. Yakut, G. Seven, H. Bozkaya, R. Idilman, C. Yurdaydin. 46th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 54 Supp No:1" bildiri kitapçığındaki “Interferon Treatment Of Delta Hepatitis: The Longer The Duration The Better The Success?”, S290 pp., Berlin, Almanya, Nisan 2011 (EASL Genc Arastirmaci Odulu). 
B19:    M. Yakut, M. Bektas, G. Seven, G Kabaçam, E. Karataylı, S. Karataylı, A.M. Bozdayı, R. Idilman, C. Yurdaydin. 46th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 54 Supp No:1" bildiri kitapçığındaki “Characterizatıon of The Inactive Hbsag Carrier  State Wıth 3 Year Follow-Up”, S159 pp., Berlin, Almanya, Nisan 2011 
B20:    G Kabaçam, M Yakut, G Seven, SC Karatayli, C Nassiri, H Bozkaya, A.M Bozdayi, R Idilman, C Yurdaydin. The 62th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 54; S4" bildiri kitapçığındaki " Delta Hepatitis May Require Prolonged Treatment with Interferon", 1039A pp., Boston, ABD, Kasım 2011.
B21:    M. Yakut, G Kabaçam, M. Törüner, I. Soykan. The  19th annual meeting of the United European Gastroenterology Week kongresi dahilinde “Gut, volume 60 (Suppl 3)” bildiri kitapçığındaki “Clinical Characteristics, Endoscopic and Laboratory Features of Patients with Autoimmune Gastritis.”. A274pp, Stokolm, Isvec. Kasim 2011. (Seyahat Bursu)
B22:    M. Yakut, S Kutlay, G Kabaçam, A Ongun, R Boynuegri, I. Soykan. The  19th annual meeting of the United European Gastroenterology Week kongresi dahilinde “Gut, volume 60 (Suppl 3)” bildiri kitapçığındaki “Multiparametric Assessment of Vascular Function and Atherosclerosis in Patients with Autoimmune Gastritis: A Comparative Study”. A416pp, Stokolm, Isvec. Kasim 2011.
B23:    H Cetinkaya, O Keskin, M Bektas, A Tuzun, G Kabaçam, G Seven, M Yakut, H Aniktar, E Dogru, M Toruner, I Soykan, AR Beyler, K Bahar. Diverticular Disease: A Fresh Approach to a Neglected Disease konulu Falk Symposium’u bildiri kitabinda yayinlanan, “The Prevalance and Localization of Diverticulosis Coli in Turkish Population: Single – center Data” 4pp, Cologne, Almanya. Eylul, 2011.
B24:    G Kabaçam, F.O. Önder, G. Seven, M. Yakut, H. Bozkaya, M.A. Bozdayı, R. İdilman, C. Yurdaydın, 45th International Liver Congress - EASL kongresi dahilinde "Journal of Hepatology Vol. 52 Supp" bildiri kitapçığındaki "Outcome and virological changes during the follow up of a large single center cohort of chronic delta hepatitis patients", S133 pp., Viyana, Avusturya, Nisan 2010 (EASL Genc Arastirmaci Odulu).
B25:    G Seven, R Idilman, Y Bozkus, K Cinar, G Kabaçam, M Yakut, A.M Bozdayi, C Yurdaydin. The 61th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 52" bildiri kitapçığındaki " HBsAg Serocoversion Under Lamivudine in HBeAg-Negative Chronic Hepatitis B ", 545A pp., Boston, ABD, Kasım 2010
B26:    M Yakut, G Seven, B Baran, G Kabaçam, E Karatayli, A M Bozdayi, R Idilman,S Kaymakoglu, C Yurdaydin. The 61th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 52" bildiri kitapçığındaki " Clevudine Treatment of Chronic Delta Hepatitis. ", 554A pp., Boston, ABD, Kasım 2010
B27:    M Yakut, M Bektas, G Seven, G Kabaçam, E Karatayli, A M Bozdayi, R Idilman, C Yurdaydin. The 61th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 52" bildiri kitapçığındaki " Characterization of the Inactive HBsAg Carrier State. ", 558A pp., Boston, ABD, Kasım 2010
B28:    G Seval, R Idilman, K Cinar, G Seven, M Yakut, G Kabaçam, B Evranos, B Savas, K Bahar. The 61th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 52" bildiri kitapçığındaki " Identification of Risk Factors for Fibrosis Progression in Non-Alcoholic Fatty Liver Disease.", 643A pp., Boston, ABD, Kasım 2010 
B29:    G Kabaçam, FO Onder, G Seven, M Yakut, H Bozkaya, A M Bozdayi, R Idilman, C Yurdaydin. The 61th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 52" bildiri kitapçığındaki "Outcome of Chronic Delta Hepatitis: Experience Gained From A Large Single Center Cohort.", 679A pp., Boston, ABD, Kasım 2010.
B30:    AK Dökmeci, R Küper, H Özkan, H Erdal, Y Üstün, G Kabaçam, G Seven, M Palabıyıkoğlu, N Örmeci. The  20th annual meeting of the Asia Pacific Accociation for the Study of Liver Diseases kongresi dahilinde “Hepatology Int, volume 4 (Suppl 1)” bildiri kitapçığındaki “Diagnostic value of Lectin-reactive alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP) for Hepatocellular Carcinoma (HCC): First study with a Turkish patient cohort.” PP-723. Beijing, Cin. Mart 2010. 
B31:    AK Dökmeci, G Kabaçam,  S Karayalçın, M Bektaş, M Palabıyıkoğlu, H Özkan, N Örmeci. The  20th annual meeting of the Asia Pacific Accociation for the Study of Liver Diseases kongresi dahilinde “Hepatology Int, volume 4 (Suppl 1)” bildiri kitapçığındaki “Comparison of therapeutic effects between percutaneous ethanol injection therapy and radiofrequency ablation for hepatocellular carcinoma.” PP-738. Beijing, Cin. Mart 2010. 
B32:    M Yakut, G Kabaçam, Y Ustun, I Soykan. The  18th annual meeting of the United European Gastroenterology Week kongresi dahilinde “Gut, volume 59 (Suppl III)” bildiri kitapçığındaki “Serum Vitamin B12 and Folate Status in Patients with Inflammatory Bowel Diseases”. A406 – 7 pp, Barselona, Ispanya. Kasim 2010.
B33:    G Kabaçam, M. Yakut, M. Bektaş, H. Çetinkaya, M. Törüner, I. Soykan. The  18th annual meeting of the United European Gastroenterology Week kongresi dahilinde “Gut, volume 59 (Suppl III)” bildiri kitapçığındaki “The Effect of Endogenoeus Hypergastrinemia on Lower Esophageal Sphincter Pressure and Esophageal Motility”. A121pp, Barselona, Ispanya. Kasim 2010.  
B34:    G Kabaçam, H Wedemeyer, B Heidrich, K Yalçın, FO Önder, Hans P. Dienes, Michael P. Manns, C Yurdaydın. “Immunehistochemistry for HBSAG, HBCAG, and HDAG in Chronic Delta Hepatitis and effect of treatment.” EASL Monothematic Conference on Delta Hepatitis 2010. P 48, Istanbul, Turkiye. Eylul 2010. (EASL Genc Arastirmaci Odulu).
B35:    G Kabaçam, FO Önder, M Yakut, G Seven, H Bozkaya, M Bozdayı, R İdilman, C Yurdaydın. “Outcome of Chronic Delta Hepatitis experience gained from a large single center cohort.”  EASL Monothematic Conference on Delta Hepatitis 2010. P 49. Istanbul, Turkiye. Eylul 2010.
B36:    FO Önder, M Toy, JH Richardus, R İdilman, G Kabaçam, H Değertekin, K Yalçın, S Schalm, C Yurdaydın. “An aggregated analysis of delta hepatitis in Turkey and the quantification of burden of disease.” EASL Monothematic Conference on Delta Hepatitis 2010. P 74. Istanbul, Turkiye. Eylul 2010. (EASL Genc Arastirmaci Odulu)
B37:    M Yakut, G Seven, B Baran, G Kabaçam, E Karataylı, M Bozdayı, S Kaymakoğlu, R İdilman, C Yurdaydın. “Clevudine treatment of chronic delta hepatitis.” EASL Monothematic Conference on Delta Hepatitis 2010. P 93. Istanbul, Turkiye. Eylul 2010.
B38:    C Yurdaydin, G Kabaçam, Y Cakaloglu, A Erhardt, H Degertekin, S Gurel, S
Zeuzem, GN. Dalekos, H Bozkaya, HP. Dienes, MP. Manns, H Wedemeyer. 
The 60th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 50" bildiri kitapçığındaki " Efficacy of Pegylated Interferon-Based Treatment in Patients with Cirrhosis Due to Chronic Delta Hepatitis: Comparison with Non-Cirrhotic Patients.", 736A pp., Boston, ABD, Kasım 2009. 
B39:    R Idilman, G Cengiz-Seval, G Seven, K Cinar, D Mizrak, M Sayki-Arslan, G Kabaçam, Y Ustun, M Yakut, M Bektas, A Ozden. The 60th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 50" bildiri kitapçığındaki " The Characteristics and Natural Course Of Non-Alcoholic Fatty Liver Disease in a Single Center Experience.", 801A pp., Boston, ABD, Kasım 2009 
B40:    G Kabaçam, M. Bektas, M. Alkan, H. Cetinkaya, I. Soykan. The  17th annual meeting of the United European Gastroenterology Week kongresi dahilinde bildiri kitapçığındaki “Esophageal Motility is Not Impaired in Patients with Significantly Elevated Serum Gastrin Levels.” P1562, Londra, Ingiltere. Kasim 2009.
B41:    FO. Önder, M. Yakut, R. İdilman, G. Seven, G Kabaçam, E. Karataylı, S.C. Karataylı, Y. Çelik, H. Bozkaya, A.M. Bozdayı, C. Yurdaydın, The 60th annual meeting of the American Accociation for the Study of Liver Diseases kongresi dahilinde "Hepatology volume 50" bildiri kitapçığındaki "Entecavir may be beneficial in a subset of patients with chronic delta hepatitis", 735A pp., Boston, ABD, Kasım 2009
B42:    AK Dökmeci, R Küper, H Özkan, H Erdal, Y Üstün, G Kabaçam, M Yakut, G Seven, M Palabıyıkoğlu, N Örmeci. The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “Diagnostic value of Lectin-reactive alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP) for Hepatocellular Carcinoma (HCC): First study with a Turkish patient cohort.” 106 PP. Istanbul, Turkiye. Mayis 2009. 
B43:    H Ozkan, M Yakut, G Kabaçam, N Ormeci, AK Dokmeci.  The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “Hepatitis B and C Virus Coinfection Among 1036 Patients” 108 PP. Istanbul, Turkiye. Mayis 2009.
B44:    H Ozkan, G Kabaçam, P Altay, M Yakut, N Ormeci, AK Dokmeci.  The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “Correlation of the Serum HBV DNA load in HBeAg – positive and HBeAg – negative chronic hepatitis B patients” 113 PP. Istanbul, Turkiye. Mayis 2009.
B45:    H Ozkan, H Erdal, G Kabaçam, M Yakut, N Ormeci, AK Dokmeci.  The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “Alpha – 1 Antitrypsin Defficiency: A case report” 176 PP. Istanbul, Turkiye. Mayis 2009.
B46:    G Kabaçam, M. Bektas, Y Ustun, M Yakut, M Toruner, H. Cetinkaya, I. Soykan. Digestive Disease Week 2009 kongresi dahilinde “AGA Abstracts” bildiri kitapçığındaki “Clinical and Laboratory Features of Patients with Significantly Elevated Serum Gastrin Level.” A 485, Chicago, ABD. Mayis 2009. 
B47:    H Ozkan, G Kabaçam, M Yakut, N Ormeci, AK Dokmeci.  The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “HBsAg loss and seroconversion in 857 HBsAg+ patients during long term follow up” 111 PP. Istanbul, Turkiye. Mayis 2009.
B48:    N Ormeci, AK Dokmeci, S Demirci, H Ozkan, M Palabiyikoglu, S Coban, F Ekiz, O Aydinli, G Kabaçam. The 5th APASL Single Topic Conference: Non Responders konferansi dahilinde bildiri kitapçığındaki “Characteristics of hepatocellular carcinoma in Turkey” 196 PP. Istanbul, Turkiye. Mayis 2009.
B49:    A Dokmeci, M Bektas, I Halici, Y Ustun, E Oztas, K Cinar, R Idilman, M Sarioglu, G Kabaçam, M Yakut, H Ozkan, N Ormeci, H Bozkaya, S Karayalcin, C Yurdaydin. 18th World Congress of International Association of Surgeons, Gastroenterologists and Oncologists kongresi bildiri kitabi “Hepato – Gastroenterology, volüme 55, suppl 1”de yer alan: “Biliary parasitosis prevalance among the cases undergoing ERCP procedure.” A126. Istanbul. Turkiye, Ekim 2008.
B50:    A Dokmeci, M Bektas, Y Ustun, K Cinar, R Idilman, M Sarioglu, G Seven, G Kabaçam, H Ozkan, N Ormeci, H Bozkaya, S Karayalcin, C Yurdaydin. 18th World Congress of International Association of Surgeons, Gastroenterologists and Oncologists kongresi bildiri kitabi “Hepato – Gastroenterology, volüme 55, suppl 1”de yer alan: “Retrospective evaluation of the cases with chronic pankreatitis.” A287. Istanbul. Turkiye, Ekim 2008.